JP2024529170A5 - - Google Patents
Info
- Publication number
- JP2024529170A5 JP2024529170A5 JP2024508812A JP2024508812A JP2024529170A5 JP 2024529170 A5 JP2024529170 A5 JP 2024529170A5 JP 2024508812 A JP2024508812 A JP 2024508812A JP 2024508812 A JP2024508812 A JP 2024508812A JP 2024529170 A5 JP2024529170 A5 JP 2024529170A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- subject
- vector
- pharmaceutical product
- vein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163260225P | 2021-08-12 | 2021-08-12 | |
| US63/260,225 | 2021-08-12 | ||
| US202163263442P | 2021-11-02 | 2021-11-02 | |
| US63/263,442 | 2021-11-02 | ||
| US202263343985P | 2022-05-19 | 2022-05-19 | |
| US63/343,985 | 2022-05-19 | ||
| PCT/US2022/074944 WO2023019272A1 (en) | 2021-08-12 | 2022-08-12 | Retrograde coronary venous or sinus administration of therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529170A JP2024529170A (ja) | 2024-08-01 |
| JP2024529170A5 true JP2024529170A5 (https=) | 2025-08-18 |
Family
ID=85201030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508812A Pending JP2024529170A (ja) | 2021-08-12 | 2022-08-12 | 治療薬の逆行性冠状静脈又は洞投与 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260069719A1 (https=) |
| EP (1) | EP4384269A4 (https=) |
| JP (1) | JP2024529170A (https=) |
| KR (1) | KR20240063110A (https=) |
| AU (1) | AU2022325237A1 (https=) |
| CA (1) | CA3228581A1 (https=) |
| CL (1) | CL2024000397A1 (https=) |
| IL (1) | IL310763A (https=) |
| MX (1) | MX2024001939A (https=) |
| WO (1) | WO2023019272A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015117010A2 (en) | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
| WO2024229259A1 (en) * | 2023-05-02 | 2024-11-07 | Research Institute At Nationwide Children's Hospital | Gene therapy for treatment of protein misfolding diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015117010A2 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
| SG11201803934YA (en) * | 2015-11-11 | 2018-06-28 | Intrexon Corp | Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies |
-
2022
- 2022-08-12 AU AU2022325237A patent/AU2022325237A1/en active Pending
- 2022-08-12 WO PCT/US2022/074944 patent/WO2023019272A1/en not_active Ceased
- 2022-08-12 MX MX2024001939A patent/MX2024001939A/es unknown
- 2022-08-12 KR KR1020247007654A patent/KR20240063110A/ko active Pending
- 2022-08-12 IL IL310763A patent/IL310763A/en unknown
- 2022-08-12 US US18/682,875 patent/US20260069719A1/en active Pending
- 2022-08-12 CA CA3228581A patent/CA3228581A1/en active Pending
- 2022-08-12 JP JP2024508812A patent/JP2024529170A/ja active Pending
- 2022-08-12 EP EP22856854.9A patent/EP4384269A4/en active Pending
-
2024
- 2024-02-08 CL CL2024000397A patent/CL2024000397A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2967616T3 (es) | Tratamiento de AMD mediante el uso de AAV sFLT-1 | |
| US20020106381A1 (en) | Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus | |
| CN106488984A (zh) | 一种治疗周围神经病变以及运动神经元疾病的方法 | |
| US20240226399A9 (en) | Loco-regional perfusion of a kidney | |
| WO2012112578A2 (en) | Improved aav8 vector with enhanced functional activity and methods of use thereof | |
| JP2024529170A5 (https=) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| US20260062682A1 (en) | Aav-mediated gene therapy for maple syrup urine disease (msud) | |
| JP2022539238A5 (https=) | ||
| KR20250012749A (ko) | Aav 벡터를 사용한 b-세포 림프종 2-관련 안타노겐 3(bag3) 유전자 요법 | |
| Koponen et al. | AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery | |
| JP2021520811A5 (https=) | ||
| US20240307601A1 (en) | Loco-regional perfusion of a liver | |
| JP2024510108A5 (https=) | ||
| US20220403417A1 (en) | Aav-based delivery of thymine kinase 2 | |
| WO2000038518A9 (en) | Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors | |
| US20170252462A1 (en) | Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy | |
| US20060188482A1 (en) | Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal | |
| US20230241249A1 (en) | Adeno-associated virus vector for dwarf open reading frame | |
| JP2024515823A (ja) | メープルシロップ尿症（ｍｓｕｄ）におけるｂｃａａ修飾のための遺伝子治療 | |
| Chaanine et al. | Cardiac gene therapy | |
| US12274757B2 (en) | Recombinant adeno-associated viruses encoding serpin peptides and uses thereof | |
| TW202122121A (zh) | 藥物灌注到非停止(unarrested)跳動之心臟 | |
| RU2024106099A (ru) | Ретроградное коронарно-венозное или синусовое введение терапевтических агентов | |
| WO2023147584A2 (en) | Compositions and methods for treating sialidosis |